|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Reneo Pharmaceuticals (NASDAQ: RPHM) through any online brokerage.
There are no as such competitors for Reneo Pharmaceuticals.
The latest price target for Reneo Pharmaceuticals (NASDAQ: RPHM) was reported by SVB Leerink on May 4, 2021. The analyst firm set a price target for 25.00 expecting RPHM to rise to within 12 months (a possible 160.69% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Reneo Pharmaceuticals (NASDAQ: RPHM) is $9.59 last updated Wed Jun 23 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Reneo Pharmaceuticals.
There is no upcoming split for Reneo Pharmaceuticals.
Reneo Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.